StockData
Kura Oncology, Inc. logo

Kura Oncology, Inc. (KURA) stock

KURANasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 10, 2026Score 1/30
$7.34−0.15 (-2.00%)

Close on Nov 18, 2026Market cap $652.97MP/E –Yield –

Kura Oncology operating margin

Operating margin is operating income as a percentage of revenue.

Kura Oncology's operating margin for the twelve months ending Sep 30, 2026 was -394.3%. For fiscal 2025 it was -449.9%, against -358.5% the year before.

Annual operating margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025-449.9%−91.4
FY2024Dec 31, 2024-358.5%–

Quarterly operating margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q3 FY2026Sep 30, 2026-326.9%+58.6
Q2 FY2026Jun 30, 2026-349.8%+125.5
Q1 FY2026Mar 31, 2026-431.5%+27.1
Q4 FY2025Dec 31, 2025-497.6%–
Q3 FY2025Sep 30, 2025-385.5%–
Q2 FY2025Jun 30, 2025-475.3%–
Q1 FY2025Mar 31, 2025-458.6%–

More Kura Oncology figures

See a number that looks wrong?